RECRUITING

Perturbation Training Reduces Falls in People With AD

Talk to us

Conditions

Alzheimer Disease

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will examine the overall capacity of people with Alzheimer's disease learning fall-resistant skills from perturbation training.

Official Title

Motor Learning of Fall Resistant Skills From Laboratory-induced Falling Among People With Mild Alzheimer's Disease

Quick Facts

Study Start:2023-04-28
Study Completion:2025-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05205980

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:65 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participants must be at least 65 years old;
  2. * Participants have a clinical diagnosis of probable AD;
  3. * Participants can read and understand English;
  4. * Participants must be able to walk independently at least 25 feet;
  5. * Participants must be able to stand independently for at least 30 seconds;
  6. * Participants must have a Monteral Cognitive Assessment score of 11-21 or Mini Mental Status Examination score between 18 and 23.
  1. * Individuals have ever experienced perturbation training;
  2. * Individuals have hypotension or uncontrolled hypertension;
  3. * Individuals exhibit osteoporosis;
  4. * Participants suffer from coexisting psychiatric disorders, or other neurological conditions, or injuries, etc.

Contacts and Locations

Study Contact

Feng Yang, PhD
CONTACT
404-413-8357
fyang@gsu.edu

Principal Investigator

Feng Yang, PhD
PRINCIPAL_INVESTIGATOR
Georgia State University

Study Locations (Sites)

Reminiscent
Valdosta, Georgia, 31602
United States

Collaborators and Investigators

Sponsor: Georgia State University

  • Feng Yang, PhD, PRINCIPAL_INVESTIGATOR, Georgia State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-28
Study Completion Date2025-06-30

Study Record Updates

Study Start Date2023-04-28
Study Completion Date2025-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Alzheimer Disease